International Consensus of Continuous Glucose Monitor Use in Pharmacological Clinical Trials in Diabetes
- 1 April 2023
- journal article
- editorial
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 25 (4), 217-218
- https://doi.org/10.1089/dia.2023.0054
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statementThe Lancet Diabetes & Endocrinology, 2022
- Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with DiabetesDiabetes Technology & Therapeutics, 2022
- Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE StudyDiabetes Technology & Therapeutics, 2022
- Glycaemic management in diabetes: old and new approachesThe Lancet Diabetes & Endocrinology, 2021
- Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2021
- Introduction: History of Glucose MonitoringADA Clinical Compendia, 2018
- Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2015
- Hemoglobin Components in Patients with Diabetes MellitusThe New England Journal of Medicine, 1971